SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-217393
Filing Date
2019-08-09
Accepted
2019-08-09 06:40:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d789106ds3.htm S-3 337449
2 EX-4.3 d789106dex43.htm EX-4.3 296732
3 EX-4.5 d789106dex45.htm EX-4.5 116708
4 EX-4.6 d789106dex46.htm EX-4.6 113708
5 EX-4.7 d789106dex47.htm EX-4.7 105757
6 EX-5.1 d789106dex51.htm EX-5.1 26488
7 EX-23.1 d789106dex231.htm EX-23.1 1552
8 EX-23.2 d789106dex232.htm EX-23.2 1664
9 GRAPHIC g789106dsp000167.jpg GRAPHIC 3274
10 GRAPHIC g789106g10v95.jpg GRAPHIC 64255
  Complete submission text file 0001193125-19-217393.txt   1094490
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233161 | Film No.: 191011266
SIC: 2836 Biological Products, (No Diagnostic Substances)